Eolas Therapeutics Announce Initiation of a Phase I Clinical Trial for...

Eolas Therapeutics Inc. today announced the initiation of a Phase I study of AZD4041 for treating tobacco use and dependence. (PRWeb December 04, 2019) Read ... Read more

Bron:

Industry